341 related articles for article (PubMed ID: 36017071)
1. Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy.
Chen BQ; Zhao Y; Zhang Y; Pan YJ; Xia HY; Kankala RK; Wang SB; Liu G; Chen AZ
Bioact Mater; 2023 Mar; 21():1-19. PubMed ID: 36017071
[TBL] [Abstract][Full Text] [Related]
2. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches.
Elzoghby AO; Samir O; Emam HE; Soliman A; Abdelgalil RM; Elmorshedy YM; Elkhodairy KA; Nasr ML
Acta Pharm Sin B; 2024 Jun; 14(6):2475-2504. PubMed ID: 38828160
[TBL] [Abstract][Full Text] [Related]
3. Hybrid Cell Membrane-Based Nanoplatforms for Enhanced Immunotherapy against Cancer and Infectious Diseases.
Peng X; Yang L; Yuan P; Ding X
Adv Healthc Mater; 2024 May; ():e2304477. PubMed ID: 38709914
[TBL] [Abstract][Full Text] [Related]
4. Biointerface engineering nanoplatforms for cancer-targeted drug delivery.
Zhang H; Dong S; Li Z; Feng X; Xu W; Tulinao CMS; Jiang Y; Ding J
Asian J Pharm Sci; 2020 Jul; 15(4):397-415. PubMed ID: 32952666
[TBL] [Abstract][Full Text] [Related]
5. Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy.
Hussain Z; Rahim MA; Jan N; Shah H; Rawas-Qalaji M; Khan S; Sohail M; Thu HE; Ramli NA; Sarfraz RM; Abourehab MAS
J Control Release; 2021 Jul; 335():130-157. PubMed ID: 34015400
[TBL] [Abstract][Full Text] [Related]
6. Engineered Cell Membrane-Camouflaged Nanomaterials for Biomedical Applications.
Guan X; Xing S; Liu Y
Nanomaterials (Basel); 2024 Feb; 14(5):. PubMed ID: 38470744
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Engineering Nanomedicines for Second Near-Infrared Photothermal-Combinational Immunotherapy.
Wang F; Zhu J; Wang Y; Li J
Nanomaterials (Basel); 2022 May; 12(10):. PubMed ID: 35630880
[TBL] [Abstract][Full Text] [Related]
9. High-Performance Dual Combination Therapy for Cancer Treatment with Hybrid Membrane-Camouflaged Mesoporous Silica Gold Nanorods.
Li H; Peng Q; Yang L; Lin Y; Chen S; Qin Y; Li S; Yu X; Zhang L
ACS Appl Mater Interfaces; 2020 Dec; 12(52):57732-57745. PubMed ID: 33326211
[TBL] [Abstract][Full Text] [Related]
10. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
11. Stimuli-Sheddable Nanomedicine Overcoming Pathophysiological Barriers for Potentiating Immunotherapy of Cancer.
Wang J; Zhou M; Chen F; Liu X; Gao J; Wang W; Wang H; Yu H
J Biomed Nanotechnol; 2021 Aug; 17(8):1486-1509. PubMed ID: 34544528
[TBL] [Abstract][Full Text] [Related]
12. Semiconducting Polymers for Cancer Immunotherapy.
Li W; Liang M; Qi J; Ding D
Macromol Rapid Commun; 2023 Dec; 44(23):e2300496. PubMed ID: 37712920
[TBL] [Abstract][Full Text] [Related]
13. Tumor Immune Microenvironments (TIMEs): Responsive Nanoplatforms for Antitumor Immunotherapy.
Sui X; Jin T; Liu T; Wu S; Wu Y; Tang Z; Ren Y; Ni D; Yao Z; Zhang H
Front Chem; 2020; 8():804. PubMed ID: 33094098
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophage membrane-camouflaged pH-responsive polymeric micelles for combined cancer chemotherapy-sensitized immunotherapy.
Du T; Wang Y; Luan Z; Zhao C; Yang K
Int J Pharm; 2022 Aug; 624():121911. PubMed ID: 35700870
[TBL] [Abstract][Full Text] [Related]
16. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
17. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
Zhou L; Zhang P; Wang H; Wang D; Li Y
Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102
[TBL] [Abstract][Full Text] [Related]
18. Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells.
Yong SB; Chung JY; Song Y; Kim J; Ra S; Kim YH
Biomaterials; 2019 Oct; 219():119401. PubMed ID: 31398571
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Combination of Copper Chalcogenide-Based Photothermal and Reactive Oxygen Species-Related Therapies.
Zhao Y; Chen BQ; Kankala RK; Wang SB; Chen AZ
ACS Biomater Sci Eng; 2020 Sep; 6(9):4799-4815. PubMed ID: 33455213
[TBL] [Abstract][Full Text] [Related]
20. An erythrocyte membrane-camouflaged biomimetic nanoplatform for enhanced chemo-photothermal therapy of breast cancer.
Li JQ; Zhao RX; Yang FM; Qi XT; Ye PK; Xie M
J Mater Chem B; 2022 Mar; 10(12):2047-2056. PubMed ID: 35254366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
